Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
(Q37031936)
scientific article published on June 1, 1992
scientific article published on June 1, 1992
Language: